DE69832075D1 - Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks - Google Patents

Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks

Info

Publication number
DE69832075D1
DE69832075D1 DE69832075T DE69832075T DE69832075D1 DE 69832075 D1 DE69832075 D1 DE 69832075D1 DE 69832075 T DE69832075 T DE 69832075T DE 69832075 T DE69832075 T DE 69832075T DE 69832075 D1 DE69832075 D1 DE 69832075D1
Authority
DE
Germany
Prior art keywords
eprosartan
treatment
high pressure
systolic blood
isolated systolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69832075T
Other languages
English (en)
Other versions
DE69832075T2 (de
Inventor
David P Brooks
Giora Z Feuerstein
Eliot H Ohlstein
Robert R Ruffolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE69832075D1 publication Critical patent/DE69832075D1/de
Application granted granted Critical
Publication of DE69832075T2 publication Critical patent/DE69832075T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69832075T 1997-05-27 1998-05-27 Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks Expired - Lifetime DE69832075T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4780097P 1997-05-27 1997-05-27
US47800P 1997-05-27
PCT/US1998/010794 WO1998053816A1 (en) 1997-05-27 1998-05-27 Method of treating isolated systolic hypertension

Publications (2)

Publication Number Publication Date
DE69832075D1 true DE69832075D1 (de) 2005-12-01
DE69832075T2 DE69832075T2 (de) 2006-07-13

Family

ID=21951046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69832075T Expired - Lifetime DE69832075T2 (de) 1997-05-27 1998-05-27 Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks

Country Status (24)

Country Link
US (1) US20020040045A1 (de)
EP (1) EP1003506B1 (de)
JP (1) JP2002500673A (de)
KR (1) KR20010013014A (de)
CN (1) CN1257427A (de)
AR (1) AR012872A1 (de)
AT (1) ATE307580T1 (de)
AU (1) AU740646B2 (de)
BR (1) BR9809611A (de)
CA (1) CA2288722C (de)
CZ (1) CZ298390B6 (de)
DE (1) DE69832075T2 (de)
ES (1) ES2251083T3 (de)
HU (1) HUP0003249A3 (de)
IL (1) IL132154A (de)
MX (1) MXPA99010970A (de)
NO (1) NO326141B1 (de)
NZ (1) NZ337888A (de)
PL (1) PL191971B1 (de)
SA (1) SA98190174B1 (de)
TR (1) TR199902914T2 (de)
TW (1) TW579296B (de)
WO (1) WO1998053816A1 (de)
ZA (1) ZA984421B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544080A (en) * 1895-08-06 Centrifugal filtering-machine
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
JPH05199342A (ja) * 1991-05-20 1993-08-06 Xerox Corp 無声の手書きによる携帯式通信装置および方法

Also Published As

Publication number Publication date
IL132154A (en) 2002-12-01
CA2288722C (en) 2007-04-24
EP1003506A1 (de) 2000-05-31
BR9809611A (pt) 2000-07-04
NO995797D0 (no) 1999-11-26
TR199902914T2 (xx) 2000-06-21
DE69832075T2 (de) 2006-07-13
CA2288722A1 (en) 1998-12-03
SA98190174B1 (ar) 2006-05-13
EP1003506A4 (de) 2000-11-29
US20020040045A1 (en) 2002-04-04
AU740646B2 (en) 2001-11-08
AR012872A1 (es) 2000-11-22
JP2002500673A (ja) 2002-01-08
ATE307580T1 (de) 2005-11-15
EP1003506B1 (de) 2005-10-26
NZ337888A (en) 2001-04-27
AU7601798A (en) 1998-12-30
ZA984421B (en) 1998-11-27
ES2251083T3 (es) 2006-04-16
PL336886A1 (en) 2000-07-17
HUP0003249A3 (en) 2002-02-28
IL132154A0 (en) 2001-03-19
CZ298390B6 (cs) 2007-09-19
MXPA99010970A (es) 2005-07-25
PL191971B1 (pl) 2006-07-31
NO326141B1 (no) 2008-10-06
KR20010013014A (ko) 2001-02-26
CZ420099A3 (cs) 2000-09-13
TW579296B (en) 2004-03-11
WO1998053816A1 (en) 1998-12-03
NO995797L (no) 1999-11-26
CN1257427A (zh) 2000-06-21
HUP0003249A2 (hu) 2002-01-28

Similar Documents

Publication Publication Date Title
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE69817446D1 (de) Behandlung von diabetes
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69926385D1 (de) Behandlung von geweben
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE69716647T2 (de) Biologische behandlung von gebrauchten kaustischen laugen
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE69924284D1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition